Hjem › Parkinsons sygdom › New Mexico
Parkinsons sygdom kliniske forsøg i New Mexico
5 studier for Parkinsons sygdom søger deltagere på steder i New Mexico.
Byer i New Mexico
Officiel studietekst (engelsk)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of New Mexico, Albuquerque
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06680830A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #014, Albuquerque
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. sep. 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of New Mexico Health Sciences Center (Site #225), Albuquerque
RekruttererFase 2
Alder 30 til 80 · Alle køn · Opdateret 10. sep. 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of New Mexico, Albuquerque
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of New Mexico, Albuquerque
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 3. sep. 2026 · NCT07174310Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.